Trxade Group Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,091.30
2,012.00
1,117.20
2,760.10
289.00
9
Depreciation, Depletion & Amortization
4.00
4.80
3.80
-
-
-
Other Funds
-
160.00
-
-
-
179.70
Funds from Operations
899.00
1,044.30
227.30
876.80
674.50
188.70
Changes in Working Capital
54.40
20.30
136.90
373.20
502.90
84.70
Net Operating Cash Flow
844.60
1,064.60
90.40
503.50
171.70
273.40
Capital Expenditures
11.00
-
-
-
-
Net Investing Cash Flow
11.00
-
1,114.20
181.90
-
Issuance/Reduction of Debt, Net
53.40
53.40
405.00
321.10
252.70
Net Financing Cash Flow
936.50
1,685.90
406.70
621.40
2.40
Net Change in Cash
80.90
621.30
617.10
64.00
169.20
Free Cash Flow
855.60
1,064.60
-
-
171.70
Change in Capital Stock
883.10
1,579.30
1.70
300.20
250.30
Other Uses
-
-
1,114.20
181.90
-

About Trxade Group

View Profile
Address
3840 Land O'Lakes Boulevard
Land O' Lakes Florida 34639
United States
Employees -
Website http://www.trxadegroup.com
Updated 07/08/2019
Trxade Group, Inc. provides an on-line platform for pharmaceutical purchasers. It owns and operates a business-to-business web-based marketplace focuses on the United States pharmaceutical industry. It operates web-based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services; provides state-licensed pharmacies and buying groups in the United States with pharmaceuticals approved by the United States Food and Drug Administration; and acts as technology consultant provider that supports their programming needs and provides research on pharmaceutical pricing and shortages in acute care and retail settings.